5 (0, 2%); HR 0, 21 (CI 0, 08; 0, 55)), risikoen for østrogenreceptor- positiv invasiv mammacancer med 83% (placebo:
5 (0.2%); HR 0.21 (CI 0.08, 0.55)), the risk of estrogen receptor (ER) positive invasive breast cancer by 83% (placebo: